Estimate Recalculated Nov 1, 2024 11:16AM EST
Artal International S.C.A. has an estimated net worth of $3.32 Billion. This is based on reported shares across multiple companies, which include Omega Therapeutics, Inc., Seer, Inc., Scholar Rock Holding Corp, Generation Bio Co., LEXICON PHARMACEUTICALS, INC., Blue Buffalo Pet Products, Inc., SQZ Biotechnologies Co, Ceres, Inc., WEIGHT WATCHERS INTERNATIONAL INC, GLYCOMIMETICS INC, Furiex Pharmaceuticals, Inc., CAVA GROUP, INC., and MEMORY PHARMACEUTICALS CORP.
Artal International S.C.A.'s CIK is 0001218180
2023 was Artal International S.C.A.'s most active year for acquiring shares with 6 total transactions. Artal International S.C.A.'s most active month to acquire stocks was the month of May. 2023 was Artal International S.C.A.'s most active year for disposing of shares, totalling 6 transactions. Artal International S.C.A.'s most active month to dispose stocks was the month of May. 2023 saw Artal International S.C.A. paying a total of $0.00 for 32,007,990 shares, this is the most they've acquired in one year. In 2024 Artal International S.C.A. cashed out on 14,500,000 shares for a total of $1,280,010,000.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!